Skip to main content
. 2012 Jul 25;7(7):e41587. doi: 10.1371/journal.pone.0041587

Figure 3. Prevalence of pcpA, psrP and pilus-1 according to serotypes within the commercialized conjugate vaccines.

Figure 3